| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |